Phase II trial of irinotecan and raltitrexed in chemotherapy-naive advanced colorectal cancer.

Abstract

The combination irinotecan-raltitrexed is an active regimen, but the significant incidence of side-effects requires accurate patient selection and, eventually, new schedules.